Haemoglobinopathy Screen

Description
The haemoglobinopathy screen by HPLC is used in conjuction with clinical details and results of the FBC to identify Haemoglobin variants and thalassaemias. All Hb variants detected are confirmed by a secondary method. This screen is commonly used in antenatal screening, pre-operative screening and to provide HbS% for transfused sickle cell patients.
Clinical details

Screen for haemoglobin variants and thalassaemias

Related condition
Reference range

HbA2 1.8 – 3.4% of total Hb (adults only). HbF ≤1.5% of total Hb (adults only)

Synonyms

Sickle test, HbS%, Hb electrophoresis, haemoglobin electrophoresis, thalassaemia screen, SICK, HPLC, haemoglobinopathy, variant identification, sickle, antenatal screen

Testing site
Synnovis : Blood Sciences : Blackfriars Hub
Laboratory
Red Cell
Sample type and volume required

Whole blood in EDTA. Required volume is variable as secondary testing may be required. The minimum acceptable volume of whole blood is 1mL.

Special sample instructions

Referred in samples must be fully labelled and accompanied with a completed referral request form.  A copy of the referral form can be located in the FURTHER INFO tab.  Please provide the FBC result, antenatal status and family origins.

Storage and transport

Blood should be stored at 4°C where possible and may be transported at ambient temperature.

Turnaround time

3 working days

Contacts

Specialist Red Cell Laboratory

Phone – 020 4591 0045

Synnovis Hub

Floor 2

Friars Bridge Court

41-43 Blackfriars Road

London SE1 8NZ

Last updated:

Back to search